Abstract
Purpose of review
Thoracic radiation therapy is an effective treatment for several malignancies, such as Hodgkin’s lymphoma and breast cancer. Over the years, however, the incidence of cardiovascular events has increased in these patients, notably in younger survivors who do not have traditional risk factors. This review summarizes the pathology, incidence, clinical presentation, and management of cardiac events after radiation therapy.
Recent findings
Mediastinal radiation therapy accelerates the atherosclerosis process, resulting in early onset coronary artery disease. Valvular disease due to radiation therapy typically affects the left-sided valves, with aortic regurgitation being the most common. Rarely, it may lead to aortic stenosis requiring surgical interventions. Pericardial involvement includes acute and chronic pericardial disease and pericardial effusion. New studies are investigating the prevalence and pathogenesis of autonomic dysfunction in cancer survivors who have undergone mediastinal and neck radiation.
Summary
Radiation therapy itself causes vascular endothelial dysfunction, resulting in clinical cardiovascular events, manifesting many years after completion of therapy. There remains little guidance regarding screening and therapies to prevent cardiovascular events in this population.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance
Boivin JF, Hutchison GB, Lubin JH, Mauch P. Coronary artery disease mortality in patients treated for Hodgkin’s disease. Cancer. 1992;69(5):1241–7.
• Fidler MM, Reulen RC, Henson KE, Kelly J, Cutter D, Levitt GA, et al. Population-based long-term cardiac-specific mortality among 34,489 five-year survivors of childhood cancer in Great Britain. Circulation. 2017. doi:10.1161/CIRCULATIONAHA.116.024811. This prospective study followed patients treated for cancer in childhood. Those treated in the 1980s had a higher incidence of cardiac mortality and morbidity compared to those treated after the 1990s, suggesting that changes in the treatment process has lowered but not elimiated cardiac risk.
McGale P, Darby SC, Hall P, Adolfsson J, Bengtsson NO, Bennet AM, et al. Incidence of heart disease in 35,000 women treated with radiotherapy for breast cancer in Denmark and Sweden. Radiother Oncol. 2011;100(2):167–75. doi:10.1016/j.radonc.2011.06.016.
• Le Gallic C, Phalente Y, Manens L, Dublineau I, Benderitter M, Gueguen Y, et al. Chronic internal exposure to low dose 137Cs induces positive impact on the stability of atherosclerotic plaques by reducing inflammation in ApoE−/−mice. PLoS One. 2015;10(6):e0128539. doi:10.1371/journal.pone.0128539. This study characterized atherosclerotic lesions in mice exposed to low dose radiation.
• Linton MF, Babaev VR, Huang J, Linton EF, Tao H, Yancey PG. Macrophage apoptosis and efferocytosis in the pathogenesis of atherosclerosis. Circ J. 2016;80(11):2259–68. doi:10.1253/circj.CJ-16-0924. This review summarized the effects of macrophages on the development of atherosclerosis.
Shimizu Y, Kodama K, Nishi N, Kasagi F, Suyama A, Soda M, et al. Radiation exposure and circulatory disease risk: Hiroshima and Nagasaki atomic bomb survivor data, 1950–2003. BMJ. 2010;340:b5349. doi:10.1136/bmj.b5349.
Ng AK, Bernardo MP, Weller E, Backstrand KH, Silver B, Marcus KC, et al. Long-term survival and competing causes of death in patients with early-stage Hodgkin’s disease treated at age 50 or younger. J Clin Oncol. 2002;20(8):2101–8. doi:10.1200/JCO.2002.08.021.
Swerdlow AJ, Higgins CD, Smith P, Cunningham D, Hancock BW, Horwich A, et al. Myocardial infarction mortality risk after treatment for Hodgkin disease: a collaborative British cohort study. J Natl Cancer Inst. 2007;99(3):206–14. doi:10.1093/jnci/djk029.
Van Der Meeren A, Squiban C, Gourmelon P, Lafont H, Gaugler MH. Differential regulation by IL-4 and IL-10 of radiation-induced IL-6 and IL-8 production and ICAM-1 expression by human endothelial cells. Cytokine. 1999;11(11):831–8. doi:10.1006/cyto.1999.0497.
Bhattacharya S, Asaithamby A. Ionizing radiation and heart risks. Semin Cell Dev Biol. 2016;58:14–25. doi:10.1016/j.semcdb.2016.01.045.
• Wang Y, Boerma M, Zhou D. Ionizing radiation-induced endothelial cell senescence and cardiovascular diseases. Radiat Res. 2016;186(2):153–61. doi:10.1667/RR14445.1. This study suggested a mechanism for radiation-induced endothelial dysfunction.
Korpela E, Liu SK. Endothelial perturbations and therapeutic strategies in normal tissue radiation damage. Radiat Oncol. 2014;9:266. doi:10.1186/s13014-014-0266-7.
Taunk NK, Haffty BG, Kostis JB, Goyal S. Radiation-induced heart disease: pathologic abnormalities and putative mechanisms. Front Oncol. 2015;5:39. doi:10.3389/fonc.2015.00039. A review postulating the pathology of heart disease in radiation-exposed patients.
• Mulrooney DA, Armstrong GT, Huang S, Ness KK, Ehrhardt MJ, Joshi VM, et al. Cardiac outcomes in adult survivors of childhood cancer exposed to cardiotoxic therapy: a cross-sectional study. Ann Intern Med. 2016;164(2):93–101. doi:10.7326/M15-0424. A prospective study that showed the incidence of heart disease in patients treated with cardiotoxic radiation and chemotherapy in childhood.
• Boero IJ, Paravati AJ, Triplett DP, Hwang L, Matsuno RK, Gillespie EF, et al. Modern radiation therapy and cardiac outcomes in breast cancer. Int J Radiat Oncol Biol Phys. 2016;94(4):700–8. doi:10.1016/j.ijrobp.2015.12.018. A retrospective study that reviewed the incidence of cardiovascular disease requiring interventions in women treated with radiation for breast cancer.
Preston DL, Shimizu Y, Pierce DA, Suyama A, Mabuchi K. Studies of mortality of atomic bomb survivors. Report 13: solid cancer and noncancer disease mortality: 1950–1997. Radiat Res. 2003;160(4):381–407.
Yusuf SW, Sami S, Daher IN. Radiation-induced heart disease: a clinical update. Cardiol Res Pract. 2011;2011:317659. doi:10.4061/2011/317659.
Tungjai M, Whorton EB, Rithidech KN. Persistence of apoptosis and inflammatory responses in the heart and bone marrow of mice following whole-body exposure to 28Silicon (28Si) ions. Radiat Environ Biophys. 2013;52(3):339–50. doi:10.1007/s00411-013-0479-4.
Darby SC, Ewertz M, McGale P, Bennet AM, Blom-Goldman U, Bronnum D, et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med. 2013;368(11):987–98. doi:10.1056/NEJMoa1209825.
Heidenreich PA, Schnittger I, Strauss HW, Vagelos RH, Lee BK, Mariscal CS, et al. Screening for coronary artery disease after mediastinal irradiation for Hodgkin’s disease. J Clin Oncol. 2007;25(1):43–9. doi:10.1200/JCO.2006.07.0805.
Orzan F, Brusca A, Conte MR, Presbitero P, Figliomeni MC. Severe coronary artery disease after radiation therapy of the chest and mediastinum: clinical presentation and treatment. Br Heart J. 1993;69(6):496–500.
Marks LB, Yu X, Prosnitz RG, Zhou SM, Hardenbergh PH, Blazing M, et al. The incidence and functional consequences of RT-associated cardiac perfusion defects. Int J Radiat Oncol Biol Phys. 2005;63(1):214–23. doi:10.1016/j.ijrobp.2005.01.029.
Gayed IW, Liu HH, Yusuf SW, Komaki R, Wei X, Wang X, et al. The prevalence of myocardial ischemia after concurrent chemoradiation therapy as detected by gated myocardial perfusion imaging in patients with esophageal cancer. J Nucl Med. 2006;47(11):1756–62.
• Caro-Codon J, Jimenez-Valero S, Galeote G, Sanchez-Recalde A, Moreno R. Radiation-induced coronary artery disease: useful insights from OCT. Int J Cardiol. 2016;202:535–6. doi:10.1016/j.ijcard.2015.09.095. A case study that showed the morphology of coronary vessels affected by radiation therapy using optical coherence tomography.
Reinders JG, Heijmen BJ, Olofsen-van Acht MJ, van Putten WL, Levendag PC. Ischemic heart disease after mantlefield irradiation for Hodgkin’s disease in long-term follow-up. Radiother Oncol. 1999;51(1):35–42.
Brosius 3rd FC, Waller BF, Roberts WC. Radiation heart disease: analysis of 16 young (aged 15 to 33 years) necropsy patients who received over 3,500 rads to the heart. Am J Med. 1981;70(3):519–30.
Brown ML, Schaff HV, Sundt TM. Conduit choice for coronary artery bypass grafting after mediastinal radiation. J Thorac Cardiovasc Surg. 2008;136(5):1167–71. doi:10.1016/j.jtcvs.2008.07.005.
• Skytta T, Tuohinen S, Boman E, Virtanen V, Raatikainen P, Kellokumpu-Lehtinen PL. Troponin T-release associates with cardiac radiation doses during adjuvant left-sided breast cancer radiotherapy. Radiat Oncol. 2015;10:141. doi:10.1186/s13014-015-0436-2. This study showed that during radiation, troponin-T levels were elevated, though it is still unclear whether this increase correlates with cardiovascular damage.
•Gomez DR, Yusuf SW, Munsell MF, Welsh JW, Liao Z, Lin SH, et al. Prospective exploratory analysis of cardiac biomarkers and electrocardiogram abnormalities in patients receiving thoracic radiation therapy with high-dose heart exposure. J Thorac Oncol. 2014;9(10):1554–60. doi:10.1097/JTO.0000000000000306. This study demonstrated elevated brain natriuretic peptide, troponin-I, and electrocardiogram changes after radiation therapy. Further investigation is warranted to determine whether these biomarkers could be used to screen for cardiovascular risks in cancer survivors treated with radiation.
Kozak KR, Hong TS, Sluss PM, Lewandrowski EL, Aleryani SL, Macdonald SM, et al. Cardiac blood biomarkers in patients receiving thoracic (chemo) radiation. Lung Cancer. 2008;62(3):351–5. doi:10.1016/j.lungcan.2008.03.024.
• Bijl JM, Roos MM, van Leeuwen-Segarceanu EM, Vos JM, Bos WJ, Biesma DH, et al. Assessment of valvular disorders in survivors of Hodgkin’s lymphoma treated by mediastinal radiotherapy ± chemotherapy. Am J Cardiol. 2016;117(4):691–6. doi:10.1016/j.amjcard.2015.11.027. This study found that asymptomatic aortic regurgitation is the most common valvular disease and was more prevalent the more years after radiation exposure.
Cutter DJ, Schaapveld M, Darby SC, Hauptmann M, van Nimwegen FA, Krol AD et al. Risk of valvular heart disease after treatment for Hodgkin lymphoma. J Natl Cancer Inst. 2015;107(4). doi:10.1093/jnci/djv008. This retrospective study reviewed the incidence of valvular heart disease in patients treated with radiation therapy for Hodgkin lymphoma.
Veinot JP, Edwards WD. Pathology of radiation-induced heart disease: a surgical and autopsy study of 27 cases. Hum Pathol. 1996;27(8):766–73.
• Groarke JD, Nguyen PL, Nohria A, Ferrari R, Cheng S, Moslehi J. Cardiovascular complications of radiation therapy for thoracic malignancies: the role for non-invasive imaging for detection of cardiovascular disease. Eur Heart J. 2014;35(10):612–23. doi:10.1093/eurheartj/eht114. This review article suggested the use of non-invasive cardiac imaging to screen patients treated with radiation therapy for cardiovascular complications.
Heidenreich PA, Hancock SL, Lee BK, Mariscal CS, Schnittger I. Asymptomatic cardiac disease following mediastinal irradiation. J Am Coll Cardiol. 2003;42(4):743–9.
• Cuomo JR, Sharma GK, Conger PD, Weintraub NL. Novel concepts in radiation-induced cardiovascular disease. World J Cardiol. 2016;8(9):504–19. doi:10.4330/wjc.v8.i9.504. This review summarizes the effects of radiation therapy on the heart in cancer survivors.
• Ogino I, Watanabe S, Iwahashi N, Kosuge M, Sakamaki K, Kunisaki C, et al. Symptomatic radiation-induced cardiac disease in long-term survivors of esophageal cancer. Strahlenther Onkol. 2016;192(6):359–67. doi:10.1007/s00066-016-0956-1. This study found that efforts to reduce radiation exposure to the heart reduced the incidence of cardiovascular complications later in life.
Yusuf SW, Sarfaraz A, Durand JB, Swafford J, Daher IN. Management and outcomes of severe aortic stenosis in cancer patients. Am Heart J. 2011;161(6):1125–32. doi:10.1016/j.ahj.2011.03.013.
• Moreira LA, Silva EN, Ribeiro ML, Martins Wde A. Cardiovascular effects of radiotherapy on the patient with cancer. Rev Assoc Med Bras (1992). 2016;62(2):192–6. doi:10.1590/1806-9282.62.02.192. This literature review of patients treated with radiation therapy and the incidence, possible pathology, clinical symptoms and management of cardiovascular disease.
Carmel RJ, Kaplan HS. Mantle irradiation in Hodgkin’s disease. An analysis of technique, tumor eradication, and complications. Cancer. 1976;37(6):2813–25.
Mousavi N, Nohria A. Radiation-induced cardiovascular disease. Curr Treat Options Cardiovasc Med. 2013;15(5):507–17. doi:10.1007/s11936-013-0259-0.
• Nathan PC, Amir E, Abdel-Qadir H. Cardiac outcomes in survivors of pediatric and adult cancers. Can J Cardiol. 2016;32(7):871–80. doi:10.1016/j.cjca.2016.02.065. The study reviewed the incidence of cardiovascular disease in both children and adult cancer patients.
Kucharska W, Negrusz-Kawecka M, Gromkowska M. Cardiotoxicity of oncological treatment in children. Adv Clin Exp Med. 2012;21(3):281–8.
• Beukema JC, van Luijk P, Widder J, Langendijk JA, Muijs CT. Is cardiac toxicity a relevant issue in the radiation treatment of esophageal cancer? Radiother Oncol. 2015;114(1):85–90. doi:10.1016/j.radonc.2014.11.037. This study looked at patients treated with radiation therapy for esophageal cancer and looked at the incidence of cardiac disease.
Ling LH, Oh JK, Schaff HV, Danielson GK, Mahoney DW, Seward JB, et al. Constrictive pericarditis in the modern era: evolving clinical spectrum and impact on outcome after pericardiectomy. Circulation. 1999;100(13):1380–6.
Bertog SC, Thambidorai SK, Parakh K, Schoenhagen P, Ozduran V, Houghtaling PL, et al. Constrictive pericarditis: etiology and cause-specific survival after pericardiectomy. J Am Coll Cardiol. 2004;43(8):1445–52. doi:10.1016/j.jacc.2003.11.048.
Morton DL, Glancy DL, Joseph WL, Adkins PC. Management of patients with radiation-induced pericarditis with effusion: a note on the development of aortic regurgitation in two of them. Chest. 1973;64(3):291–7.
Guldner L, Haddy N, Pein F, Diallo I, Shamsaldin A, Dahan M, et al. Radiation dose and long term risk of cardiac pathology following radiotherapy and anthracyclin for a childhood cancer. Radiother Oncol. 2006;81(1):47–56. doi:10.1016/j.radonc.2006.08.020.
Mezzaroma E, Di X, Graves P, Toldo S, Van Tassell BW, Kannan H, et al. A mouse model of radiation-induced cardiomyopathy. Int J Cardiol. 2012;156(2):231–3. doi:10.1016/j.ijcard.2012.01.038.
Chello M, Mastroroberto P, Romano R, Zofrea S, Bevacqua I, Marchese AR. Changes in the proportion of types I and III collagen in the left ventricular wall of patients with post-irradiative pericarditis. Cardiovasc Surg. 1996;4(2):222–6.
• Al-Kindi SG, Oliveira GH. Heart transplantation outcomes in radiation-induced restrictive cardiomyopathy. J Card Fail. 2016;22(6):475–8. doi:10.1016/j.cardfail.2016.03.014. This study followed cancer survivors who had history of chest radiation therapy and their five year survival rate post heart transplantation.
Marmagkiolis K, Finch W, Tsitlakidou D, Josephs T, Iliescu C, Best JF, et al. Radiation toxicity to the cardiovascular system. Curr Oncol Rep. 2016;18(3):15. doi:10.1007/s11912-016-0502-4. This review summarized the cardiovascular effects of radiation therapy on cancer survivors.
Totterman KJ, Pesonen E, Siltanen P. Radiation-related chronic heart disease. Chest. 1983;83(6):875–8.
Orzan F, Brusca A, Gaita F, Giustetto C, Figliomeni MC, Libero L. Associated cardiac lesions in patients with radiation-induced complete heart block. Int J Cardiol. 1993;39(2):151–6.
Adams MJ, Lipshultz SE, Schwartz C, Fajardo LF, Coen V, Constine LS. Radiation-associated cardiovascular disease: manifestations and management. Semin Radiat Oncol. 2003;13(3):346–56. doi:10.1016/S1053-4296(03)00026-2.
Rosenwinkel ET, Bloomfield DM, Arwady MA, Goldsmith RL. Exercise and autonomic function in health and cardiovascular disease. Cardiol Clin. 2001;19(3):369–87.
• Groarke JD, Tanguturi VK, Hainer J, Klein J, Moslehi JJ, Ng A, et al. Abnormal exercise response in long-term survivors of hodgkin lymphoma treated with thoracic irradiation: evidence of cardiac autonomic dysfunction and impact on outcomes. J Am Coll Cardiol. 2015;65(6):573–83. doi:10.1016/j.jacc.2014.11.035. This study demonstrated that autonomic dysfunction could be a late side effect of radiation therapy.
Hoca A, Yildiz M, Ozyigit G. Evaluation of the effects of mediastinal radiation therapy on autonomic nervous system. Med Oncol. 2012;29(5):3581–6. doi:10.1007/s12032-012-0237-5.
Aung T, Fan W, Krishnamurthy M. Recurrent syncope, orthostatic hypotension and volatile hypertension: think outside the box. J Community Hosp Intern Med Perspect. 2013;3(2). doi:10.3402/jchimp.v3i2.20741.
Huang CC, Huang TL, Hsu HC, Chen HC, Lin HC, Chien CY, et al. Long-term effects of neck irradiation on cardiovascular autonomic function: a study in nasopharyngeal carcinoma patients after radiotherapy. Muscle Nerve. 2013;47(3):344–50. doi:10.1002/mus.23530.
Sharabi Y, Dendi R, Holmes C, Goldstein DS. Baroreflex failure as a late sequela of neck irradiation. Hypertension. 2003;42(1):110–6. doi:10.1161/01.HYP.0000077441.45309.08.
Mulrooney DA, Yeazel MW, Kawashima T, Mertens AC, Mitby P, Stovall M, et al. Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohort. BMJ. 2009;339:b4606. doi:10.1136/bmj.b4606.
van der Pal HJ, van Dalen EC, van Delden E, van Dijk IW, Kok WE, Geskus RB, et al. High risk of symptomatic cardiac events in childhood cancer survivors. J Clin Oncol. 2012;30(13):1429–37. doi:10.1200/JCO.2010.33.4730.
• Daniels LA, Krol AD, de Graaf MA, Scholte AJ, Van’t Veer MB, Putter H, et al. Screening for coronary artery disease after mediastinal irradiation in Hodgkin lymphoma survivors: phase II study of indication and acceptancedagger. Ann Oncol. 2014;25(6):1198–203. doi:10.1093/annonc/mdu130. This study looked at computed tomography coronary angiography as a possible screening tool for radiation induced coronary artery disease.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
This article is part of the Topical Collection on Coronary Heart Disease
Rights and permissions
About this article
Cite this article
Raghunathan, D., Khilji, M.I., Hassan, S.A. et al. Radiation-Induced Cardiovascular Disease. Curr Atheroscler Rep 19, 22 (2017). https://doi.org/10.1007/s11883-017-0658-x
Published:
DOI: https://doi.org/10.1007/s11883-017-0658-x